|
|
|
Volumn 16, Issue 4, 1996, Pages 113-122
|
|
Recent progress in development of psychotropic drugs (3) antiparkinsonian agents applied in the trea tment of Parkinson's disease or are under investigation for patients or model animals
a
|
|
Author keywords
Dopaminergic neuron; Model animals; Parkinson's Disease
|
|
Indexed keywords
AMANTADINE;
AMEZINIUM;
AROTINOLOL;
BENSERAZIDE PLUS LEVODOPA;
BIPERIDEN;
BROMOCRIPTINE MESILATE;
CARBIDOPA PLUS LEVODOPA;
CATECHOL METHYLTRANSFERASE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DECARBOXYLASE INHIBITOR;
LEVODOPA;
METHYLPHENIDATE;
MIDODRINE;
MONOAMINE OXIDASE INHIBITOR;
N METHYL DEXTRO ASPARTIC ACID;
PERGOLIDE MESILATE;
PIMOZIDE;
TALIPEXOLE;
THREO 3,4 DIHYDROXYPHENYLSERINE;
TRIHEXYPHENIDYL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CLINICAL FEATURE;
DEPRESSION;
DOPAMINE METABOLISM;
DOPAMINE RELEASE;
DOPAMINERGIC TRANSMISSION;
DOSE RESPONSE;
DYSKINESIA;
ENZYME INHIBITION;
HALLUCINOSIS;
HUMAN;
HUMAN TISSUE;
NONHUMAN;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
REVIEW;
SUBSTANTIA NIGRA;
VOMITING;
ANIMALS;
ANTIPARKINSON AGENTS;
CHOLINERGIC ANTAGONISTS;
DISEASE MODELS, ANIMAL;
DOPAMINE AGENTS;
G(M1) GANGLIOSIDE;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
NICOTINIC AGONISTS;
PARKINSON DISEASE;
RECEPTORS, DOPAMINE;
RECEPTORS, N-METHYL-D-ASPARTATE;
RECEPTORS, PURINERGIC P1;
|
|
EID: 0029816419
PISSN: 13402544
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
